Latest Interviews
Showing 6001–6015 of 6,329 interview transcripts.
Clear all filters- Goldman Sachs21 min
Steve Coll: The Fight for the Future of Afghanistan
Former Washington Post correspondent and Pulitzer Prize winner Steve Kahl presents a critical analysis of U.S. strategic failures in Afghanistan, arguing that recurring misjudgments by three administrations resulted in ambiguous objectives and an inability to distinguish between the Taliban and Al-Qaeda. Kahl evaluates recent tactical shifts under the Trump administration as insufficient for winning the war, citing data that shows no significant change in territorial control despite increased troop pressure and policy hardening. The discussion concludes by examining how these historical policy errors inform the current evolution of journalism education at Columbia University, which is increasingly prioritizing data analysis and accountability reporting over traditional narrative styles.
- 80,000 Hours2h 17m
#27 - Dr Tom Inglesby on careers and policies that reduce global catastrophic biological risks
Dr Tom Inglesby, Keiran Harris, Rob Wiblin
Dr. Thomas Inglesby of the Johns Hopkins Center for Health Security advocates for integrating catastrophic biological risk planning into existing public health and biosecurity frameworks rather than treating them as separate, siloed endeavors. He emphasizes that while natural pandemics currently pose the highest probability of threat, the rising accessibility of biotechnology necessitates a unified US Biodefense Strategy and sustained funding for initiatives like the Global Health Security Agenda to address both accidental and deliberate misuse. By promoting interdisciplinary training through programs like the Emerging Leaders Fellowship and urging legislative support for dedicated emergency response funds, Inglesby seeks to shift the system from reactive crisis management to proactive, resilient infrastructure.
- Goldman Sachs16 min
Boyan Slat: Combatting Plastic Pollution in the World’s Oceans
Founder and CEO Boyan Slat's organization is advancing a fleet of 60 passive, U-shaped floating barriers designed to remove 50% of the Great Pacific Garbage Patch within five years by leveraging natural ocean currents rather than traditional active fishing methods. Following a rigorous development cycle marked by early prototype failures and a $40 million capital raise, the system has evolved from inflatable chambers to solid pipe structures and is currently undergoing assembly at a facility near San Francisco for a targeted July launch. This initiative addresses an annual economic cost of $13 billion and a threat to 800 marine species by simultaneously targeting legacy accumulation in the Pacific and intercepting the roughly 2 million tons of river-borne plastic entering the ocean each year.
- Y Combinator28 min
Anne Wojcicki : How to Build the Future
Anne Wojcicki, William Brangham, Dr. Kathleen King
Anne Wojcijk founded 23andMe to democratize genomic data by shifting healthcare incentives from illness monetization to preventative health, despite initial skepticism from medical professionals regarding direct-to-consumer genetic testing. Overcoming early market volatility and a regulatory transition, the company now boasts a community of over five million customers and has secured FDA approvals to leverage its massive dataset for drug discovery and large-scale intervention studies. This persistent execution of a decade-long vision aims to eventually enable personalized longevity strategies by linking genetic profiles with environmental factors like diet and exercise.
- Goldman Sachs25 min
James Forman, Jr.: Rethinking Race and Criminal Justice Reform
James Forman, Jr., Cork Golumbik, James Swarman Jr.
Yale Law professor and former prosecutor James Swarman Jr. leverages his dual legal experience and background as the child of SNCC civil rights leaders to expose the internal tensions within Black political thought that fueled the rise of mass incarceration. He critiques how historical misallocations of federal resources and selective enforcement policies, such as the race-targeted "Operation Ceasefire," created collateral consequences that disproportionately punished Black communities while failing to address root causes like addiction and economic disparity. By analyzing individual case studies like that of Dante, Swarman argues against categorical legislative exclusions of "violent offenders," advocating instead for personalized rehabilitation approaches that recognize the complex narratives behind criminal behavior.
- 80,000 Hours1h 45m
#26 - Marie Gibbons on how exactly clean meat is made & the advances needed to get it in every store
Marie Gibbons, Natalie Cargill, Keiran Harris, Rob Wiblin
In this 80,000 Hours episode, host Natalie Cargill interviews Marie Gibbons, a GFI research fellow and physiologist who transitioned from veterinary medicine to champion cellular agriculture as the most viable path for global animal protection. Gibbons details the technical progression from harvesting satellite cells to scaling production using suspension bioreactors and plant-based scaffolds, while noting that cost reductions will likely drive market entry within the current year. Although the field faces logistical hurdles regarding media costs and regulatory approval, the discussion emphasizes a strategic industry shift toward specialization and collaboration to achieve cost parity with conventional meat within a decade.
- Goldman Sachs17 min
Daniel Schwartz: The Millennial CEO Changing the Fast Food Industry
Daniel Schwartz, Jennifer Coppola
Daniel Schwartz, CEO of Restaurant Brands International, leads Burger King, Tim Hortons, and Popeyes by applying 3G Capital’s meritocratic ownership model to revitalize operations and accelerate young leadership. This strategy includes mandatory frontline shifts for executives, streamlined menus to boost profitability, and equity incentives that replace tenure-based promotion with performance-driven advancement. Under Schwartz’s direction, the parent company has shifted its product focus toward authentic ingredients while leveraging a generational mindset to drive technological self-disruption across the global foodservice sector.
- Y Combinator55 min
Cost vs Quality in Edtech – Keith Schacht, Avichal Garg, and Geoff Ralston
Keith Schacht, Avichal Garg, Geoff Ralston
Avicii and Keith Peltz examine the evolution of EdTech since 2011, analyzing how the industry's historical struggle with the "cost versus quality" trade-off and misaligned venture capital expectations for growth curves have shaped current market dynamics. They identify a pivotal structural shift where high-speed internet access and teacher-led adoption are dismantling the "free school" barrier, enabling companies like Mystery Science to prove that superior digital products can succeed in the mass market. The founders conclude that future innovation will likely bypass traditional public systems to focus on "learning companies" addressing individual outcomes, job training, and adult self-directed education rather than relying on institutional bureaucracy.
- a16z8 min
Consolidation in Healthcare: What to Make of It?
Jorge Conde, Vijay Pande, Jeffrey Low
Leading healthcare entities are pursuing divergent consolidation strategies, exemplified by Walmart's potential acquisition of Humana to create a vertically integrated retail-insurance model, while Amazon, Berkshire Hathaway, and JPMorgan develop a dispersed employer consortium. Analysts predict that local integration offers more immediate cost reductions than geographically scattered employer alliances, prompting new market entrants to build proprietary pharmacy benefit management capabilities and specialized logistics for complex gene and cell therapies. This sector-wide shift toward vertical monoliths and advanced therapeutic infrastructure is creating entrepreneurial opportunities focused on digital therapeutic reimbursement and friction-free administrative frameworks.
- Goldman Sachs25 min
Amy Chua: Political Tribalism and American Foreign Policy
Yale Law professor Amy Chua analyzes global and domestic group dynamics through her concept of the "supergroup," contrasting the United States' unique ability to balance national unity with subgroup flourishing against the assimilationist models of France and China. She attributes rising U.S. political polarization to demographic shifts that have created defensive tribalism between coastal elites and the white majority, a division she attributes to a rhetorical shift from universalism to identity politics. Chua concludes by proposing practical remedies such as a national service "gap year" to foster intergroup interaction and arguing that allowing controversial speech prevents extremism from festering in epistemological silos.
- Goldman Sachs28 min
André Aciman: The Meaning and Message of 'Call Me By Your Name'
Author and distinguished CUNY professor Andre Aciman discusses the autobiographical origins of *Call Me By Your Name*, explaining how his fragmented Egyptian-Italian-American identity and childhood obsessions shaped the novel's exploration of ambiguous desire and the "San Clemente syndrome." He details the adaptation process by director Luca Guadagnino, noting how the film condensed written dialogue into improvisational screen time while preserving the story's core tension between articulation and the unspoken. Aciman further reflects on the work's emotional resonance, arguing that the text captures the universal human tendency to mourn a fabricated fantasy of what "might have happened" rather than accepting the reality of the present.
- a16z7 min
Pande & Conde on: Players and Paths for Healthcare Startups
The discussion outlines a strategic framework for healthcare startups, contrasting the lengthy regulatory paths of therapies and diagnostics with the rapid market entry offered by Laboratory-Developed Tests and R&D tool sales. Highlighting the $75 billion U.S. R&D market, the analysis features success stories like Atomab and Illumina to demonstrate how founders can leverage non-exclusive licensing models instead of pursuing costly end-user commercialization. Ultimately, the presentation advises entrepreneurs to align their go-to-market approach with specific proof points and regulatory requirements, choosing between partnership-based platforms and integrated drug development based on their technology's unique capabilities.
- 80,000 Hours2h 40m
#25 - Prof Robin Hanson on why we have to lie to ourselves about why we do what we do
Robin Hanson, Rob Wiblin, Kevin Simler
Robin Hanson argues that human behavior across education, religion, and charity is driven primarily by subconscious signaling motives to avoid violating social norms rather than by stated functional goals. This evolutionary framework explains why institutions prioritize credentialing and ritual over actual efficacy, creating a disconnect between conscious narratives and the real drivers of reproductive fitness and social status. To address these inefficiencies, Hanson proposes implementing decision markets and "marginal charity" strategies that align individual signaling incentives with tangible societal improvements while bypassing the political resistance of established elites.
- Y Combinator54 min
Breaking Down HackerRank's Survey of 40,000 Developers with Vivek Ravisankar
Vivek Ravisankar, Hari, Paul Bouquet, PG, Sam, Jessica, Akshay, Shiv, Nicola, Ritika, Mark Mandelbaum Kosinskiy
HackerRank co-founder Vivek Desai recounts the company's evolution from a failed educational venture to a global platform that connects over 3.4 million developers with employers through verified coding assessments rather than traditional resumes. As the first Indian-based Y Combinator company, the team overcame logistical hurdles to establish a market shift toward skill-based hiring, effectively reducing bias and replacing abstract brain teasers with practical problem-solving challenges. Recent data from their community highlights key industry trends, including a surge in self-taught programmers, the rising demand for Python and Go skills, and a corporate move toward prioritizing work-life balance and remote talent acquisition.
- Goldman Sachs17 min
Deborah DiSanzo: Solving the World’s Health Problems of the Future
Deborah DiSanzo, Christina Minnis
Former healthcare executive Deborah DeSanza leads IBM Watson Health's initiative to integrate artificial intelligence and cloud computing with clinical expertise, achieving tangible results such as reducing breast cancer trial matching times by 75% at the Mayo Clinic and accelerating drug discovery from 18 months to under 12 weeks. By partnering with major industry consortia to aggregate millions of patient records, the organization aims to alleviate physician burnout caused by electronic health record burdens while lowering costs through real-world evidence generation. Under the strategic direction of IBM Chairman Ginni Rometty, this approach shifts the technology firm from legacy hardware to a dominant position in AI-driven healthcare solutions that prioritize patient data ownership and life-saving outcomes.